Search Results for keywords:"compliance strategies"

Found 2 results

Search Results: keywords:"compliance strategies"

💰 Only
Oldest Newest
  • 2025-00574 — Rules of Practice and Procedure; Adjusting Civil Money Penalties for Inflation
    💰
    Type:Rule
    Citation:90 FR 2922
    Reading Time:about 4 minutes

    The Farm Credit System Insurance Corporation (FCSIC) has issued a final rule addressing adjustments to civil money penalties (CMPs), in compliance with the 2015 amendments to the Federal Civil Penalties Inflation Adjustment Act of 1990. These adjustments ensure that penalties remain effective as a deterrent by accounting for inflation, with new amounts applying from January 15, 2025, for any conduct from November 2, 2015, onward. The updated penalty for violations under section 5.65(c) or (d) of the Farm Credit Act is $264 per day. This rule bypasses standard procedure for public comment due to statutory requirements.

    Simple Explanation

    The Farm Credit System Insurance Corporation has decided to make the money penalties bigger to keep up with price changes over time, kind of like making an allowance bigger as things get more expensive. They did this because the rules say they have to, and starting January 15, 2025, breaking certain rules will cost $264 each day.

  • 2025-04978 — Nonprescription Drug Product With an Additional Condition for Nonprescription Use
    Type:Rule
    Citation:90 FR 13553
    Reading Time:about 4 minutes

    The Food and Drug Administration (FDA) issued a rule regarding nonprescription drugs that require additional conditions for safe use. Originally set to take effect on January 27, 2025, the rule has been delayed twice and is now effective on May 27, 2025, due to a review process triggered by a presidential memorandum. The new rule establishes specific requirements for drug applications, labeling, and reporting related to these nonprescription drugs. The FDA intends to use this extra time for a thorough review, as immediate public input was deemed impractical and potentially against public interests, to ensure that entities affected by the rule have sufficient time to adjust their compliance strategies.

    Simple Explanation

    The FDA made a rule about how some over-the-counter drugs need special conditions to be used safely, but they decided to wait a little longer before starting the new rule, so everyone has more time to get ready.